liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Small procoagulant platelets in diabetes type 2
Region Östergötland, Local Health Care Services in East Östergötland, Department of Internal Medicine in Norrköping.
Region Östergötland, Local Health Care Services in East Östergötland, Department of Internal Medicine in Norrköping.
Region Östergötland, Local Health Care Services in East Östergötland, Department of Internal Medicine in Norrköping.
2020 (English)In: Thrombosis Research, ISSN 0049-3848, E-ISSN 1879-2472, Vol. 195Article in journal (Refereed) Published
Abstract [en]

Background: Strong agonist provocation in vitro creates small procoagulant platelets characterized by down-regulated fibrinogen receptors as judged from surface alpha(IIb)beta(3) activation specific antibody (PAC-1). They further show increased surface Annexin V (binds to platelet membrane phosphatidylserine), lysosomal-associated membrane protein 1 (LAMP-1) (indicates lysosomal release) and exhibit disturbed mitochondria integrity as estimated from mitochondrial transmembrane potential changes. We postulated that some circulating platelets activate continuously thereby forming procoagulant populations in vivo. This study aimed to identify such platelets in diabetes type 2 a condition predisposing for thrombotic events. Methods: A linear Percoll (TM) gradient covering the density span 1.090 to 1.040 kg/L was used to separate whole blood platelets from type 2 diabetic subjects (n = 12) into 17 density subpopulations. The gradient contained theophylline, prostaglandin E1 and EDTA to prevent platelet activation in vitro. A multi-colour flow cytometer was employed for analysing the characteristics mentioned above for all density separated small-sized platelet subfractions. Results and conclusion: Small platelets were enriched in medium-dense subfractions (nos. 10-13) (1.065-1.053 kg/L). Their PAC-1 activities were significant lower (p < 0.001) as compared to other small-sized subpopulations. They further exposed enhanced surface Annexin V and LAMP-1 together with lower mitochondrial transmembrane potentials. In diabetes type 2 such small circulating platelets showed procoagulant features.

Place, publisher, year, edition, pages
PERGAMON-ELSEVIER SCIENCE LTD , 2020. Vol. 195
Keywords [en]
Annexin V; Fibrinogen; LAMP-1; Platelets; Platelet mitochondria
National Category
Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:liu:diva-171664DOI: 10.1016/j.thromres.2020.06.033ISI: 000583278500001PubMedID: 32629151OAI: oai:DiVA.org:liu-171664DiVA, id: diva2:1505089
Available from: 2020-11-30 Created: 2020-11-30 Last updated: 2021-05-03

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Edvardsson, MariaOweling, MagnusJaremo, Petter
By organisation
Department of Internal Medicine in Norrköping
In the same journal
Thrombosis Research
Biochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 57 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf